123 related articles for article (PubMed ID: 38063088)
1. The expression of p53, ki67 and COX-2 in erosive-type oral lichen planus.
Aziz S; Hamad S; Qasim Y
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(12):242-247. PubMed ID: 38063088
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67.
Acay RR; Felizzola CR; de Araújo N; de Sousa SO
Oral Oncol; 2006 May; 42(5):475-80. PubMed ID: 16364678
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of Bcl-2 and Ki-67 in oral lichen planus and leukoplakia with different degrees of dysplasia.
Pigatti FM; Taveira LA; Soares CT
Int J Dermatol; 2015 Feb; 54(2):150-5. PubMed ID: 25265990
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of cyclooxygenase-2 in oral lichen planus and normal oral mucosa.
Baby TK; Bindhu PR; Pillai RK; Jayanthi P
Indian J Pathol Microbiol; 2022; 65(1):8-12. PubMed ID: 35074958
[TBL] [Abstract][Full Text] [Related]
5. Differences in the expression of p53 protein in oral lichen planus based on the use of monoclonal antibodies DO7 and pAb 240.
Gonzalez-Moles MA; Gil-Montoya JA; Ruiz-Avila I; Esteban F; Bascones-Martinez A
Oral Oncol; 2008 May; 44(5):496-503. PubMed ID: 17826304
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle regulating mechanisms in oral lichen planus: molecular bases in epithelium predisposed to malignant transformation.
González-Moles MA; Bascones-Ilundain C; Gil Montoya JA; Ruiz-Avila I; Delgado-Rodríguez M; Bascones-Martínez A
Arch Oral Biol; 2006 Dec; 51(12):1093-103. PubMed ID: 16914114
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Study of p53 Expression in Patients with Erosive and Non-Erosive Oral Lichen Planus.
Shiva A; Zamanian A; Arab S; Boloki M
J Dent (Shiraz); 2018 Jun; 19(2):118-123. PubMed ID: 29854885
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia.
Sousa FA; Paradella TC; Carvalho YR; Rosa LE
J Oral Sci; 2009 Mar; 51(1):117-21. PubMed ID: 19325208
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
Mattila R; Alanen K; Syrjänen S
Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of the effect of acitretin and systemic steroid treatments on Ki-67, Bcl-2, and COX-2 levels in cutaneous lichen planus patients.
Ozturk M; Ozaydın Yavuz G; Yavuz İH; Erten R; Gunes Bilgili S; An I
Int J Dermatol; 2019 Dec; 58(12):1444-1450. PubMed ID: 31218676
[TBL] [Abstract][Full Text] [Related]
12. p53 expression in oral lichenoid lesions and oral lichen planus.
Arreaza A; Rivera H; Correnti M
Gen Dent; 2015; 63(1):69-72. PubMed ID: 25574723
[TBL] [Abstract][Full Text] [Related]
13. DNA content, Cyclooxygenase-2 expression and loss of E-cadherin expression do not predict risk of malignant transformation in oral lichen planus.
Neppelberg E; Johannessen AC
Eur Arch Otorhinolaryngol; 2007 Oct; 264(10):1223-30. PubMed ID: 17530268
[TBL] [Abstract][Full Text] [Related]
14. High proliferative activity and chromosomal instability in oral lichen planus.
Montebugnoli L; Farnedi A; Marchetti C; Magrini E; Pession A; Foschini MP
Int J Oral Maxillofac Surg; 2006 Dec; 35(12):1140-4. PubMed ID: 17095190
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-associated markers in oral lichen planus.
Dekker NP; Lozada-Nur F; Lagenaur LA; MacPhail LA; Bloom CY; Regezi JA
J Oral Pathol Med; 1997 Apr; 26(4):170-5. PubMed ID: 9176791
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic alteration of basal cells in oral lichen planus; switching keratin 19 and desmoglein 1 expression.
Shimada K; Ochiai T; Shen FC; Hasegawa H
J Oral Sci; 2018 Dec; 60(4):507-513. PubMed ID: 30146538
[TBL] [Abstract][Full Text] [Related]
17. Epithelial cell proliferation in oral lichen planus.
Taniguchi Y; Nagao T; Maeda H; Kameyama Y; Warnakulasuriya KA
Cell Prolif; 2002 Aug; 35 Suppl 1(Suppl 1):103-9. PubMed ID: 12139713
[TBL] [Abstract][Full Text] [Related]
18. In situ carcinoma developed over oral lichen planus: a case report with analysis of BUB3, p16, p53, Ki67 and SOX4 expression.
Rosa EA; Lia EN; Macedo SB; Amorim RF
J Appl Oral Sci; 2015; 23(4):442-7. PubMed ID: 26398519
[TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of Apoptosis and Cell-cycle Arrest Markers in Oral Lichen Planus.
Pérez-Sayáns M; Lorenzo-Pouso AI; Chamorro-Petronacci CM; Suárez-Peñaranda JM; Padín-Iruegas E; González-Moles MA; Marichalar-Mendía X; García-García A; Blanco-Carrión A
Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):374-381. PubMed ID: 33044228
[TBL] [Abstract][Full Text] [Related]
20. Expression and role of p53 in oral lichen planus patients.
Hadzi-Mihailovic M; Petrovic R; Raybaud H; Stanimirovic D; Ozar Koray M
J BUON; 2017; 22(5):1278-1286. PubMed ID: 29135114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
